Long term Results of a Phase I/ Ib Study of Ibrutinib in Combination with Umbralisib in Patients with Relapsed/Refractory CLL or MCL

Drug Category : Array
Conference Category : Array
Lead Author : Davids M, et al.
Published Date : 12/06/2020
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2020/06/Final-EHA-Umbra-Ibrutinib-RR-CLL-NMCL-Davids.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top